首页> 外国专利> Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)

Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)

机译:优化的针对组织因子途径抑制剂(TFPI)的单克隆抗体

摘要

#$%^&*AU2018271420B220200305.pdf#####Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) Abstract Isolated monoclonal antibodies that bind human tissue factor pathway inhibitor (TFPI) are provided. Isolated nucleic acid molecules encoding monoclonal antibodies that bind TFPI are also contemplated. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. Methods of producing the antibodies are also provided. H:intInterwovenNRPortblDCCFMT12333673_1.docx - 9/12/16
机译:#$%^&* AU2018271420B220200305.pdf #####针对组织因子途径抑制剂(TFPI)的优化单克隆抗体抽象结合人类组织因子途径抑制剂(TFPI)的分离的单克隆抗体是提供。编码结合TFPI的单克隆抗体的分离核酸分子也可以考虑。包含抗TFPI单克隆抗体的药物组合物抗体和通过给予抗凝剂治疗凝血缺陷或缺陷的方法还提供了抗体。还提供了产生抗体的方法。H: fint Interwoven NRPortbl DCC FMT 12333673_1.docx-16/9/12

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号